LTR Pharma Ltd: Annual Report to shareholders
LTR Pharma Ltd: Notice of Annual General Meeting/Proxy Form
LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma Ltd: SPONTAN Final Study Results
LTR Pharma Ltd: Appendix 4G and Corporate Governance Statement
LTR Pharma Ltd: FY24 Results Announcement
LTR Pharma Ltd: Appendix 4E and Annual Financial Report
LTR Pharma Ltd: SPONTAN Prescribed to First Patient by Authorised Prescriber
LTR Pharma Ltd: LTP Secures Global CoDevelopment Agreement with Aptar Pharma
LTR Pharma Ltd: Mens Health Expert Prescribes SPONTAN
LTR Pharma Ltd: SPONTAN prescribed to First Patient Under TGA
LTR Pharma Ltd: Cleansing Notice
LTR Pharma Ltd: Application for quotation of securities - LTP
LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma Ltd: Investor Webinar
LTR Pharma Ltd: Investor Presentation
LTR Pharma Ltd: Proposed issue of securities - LTP
LTR Pharma Ltd: LTR Pharma completes A$10.5 million placement
LTR Pharma Ltd: Trading Halt
LTR Pharma Ltd: Reinstatement to quotation
No Data
No Data